HAIR Financials 07/16/2014 19:02:04 Biostem U.S.
Post# of 13
Biostem U.S. Corp
Period Ending Feb 29, 2012 Feb 28, 2011 Feb 28, 2010
Total Revenue 95 15 -
Cost of Revenue 38 2 -
Gross Profit 56 13 -
Operating Expenses
Research and Development - - -
Sales, General and Admin. 3,369 193 17
Non-Recurring Items - - 10
Other - - -
Operating Income (3,337) (180) (27)
Income From Continuing Operations
Add'l Income/Expense Items - - 1
Earnings Before Interest and Tax (3,337) (180) (26)
Interest Expense - - -
Earnings Before Tax (3,337) (180) (26)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (3,337) (180) (26)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (3,337) (180) (26)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (3,337) (180) (26)